Accelerate Diagnostics Inc (AXDX) - Product Pipeline Analysis, 2019 Update

Summary

Accelerate Diagnostics Inc (Accelerate) is an in vitro diagnostics company that undertakes the development and commercialization of instrumentations for the identification and testing of antibiotic susceptibility of infectious pathogens. Its product portfolio includes Accelerate Pheno system, a platform for the identification (ID) and antibiotic susceptibility testing (AST) of infectious pathogens; and Accelerate PhenoTest BC kit which provides ID and AST results for patients suspected of bacteremia or fungemia. Accelerate uses its proprietary molecular identification methods and morphokinetic cellular analysis to provide quantitative ID/AST results. The company has a manufacturing facility in Tucson Arizona. It sells products to hospital microbiology laboratories through a direct sales force. Accelerate is headquartered in Tucson, Arizona, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Accelerate Diagnostics Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


Accelerate Diagnostics Inc Company Overview
Accelerate Diagnostics Inc Company Snapshot
Accelerate Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview
Accelerate Diagnostics Inc – Pipeline Analysis Overview
Business Description
Accelerate Diagnostics Inc - Key Facts
Accelerate Diagnostics Inc - Major Products and Services
Accelerate Diagnostics Inc Pipeline Products by Development Stage
Accelerate Diagnostics Inc Ongoing Clinical Trials by Trial Status
Accelerate Diagnostics Inc Pipeline Products Overview
Accelerate ID/AST System - Secondary Infections
Accelerate ID/AST System - Secondary Infections Product Overview
Accelerate ID/AST System - Secondary Infections Clinical Trial
Accelerate ID/AST System - Wound Infections
Accelerate ID/AST System - Wound Infections Product Overview
Accelerate ID/AST System - Wound Infections Clinical Trial
Accelerate ID/AST System - Carbepenem Resistance Testing
Accelerate ID/AST System - Carbepenem Resistance Testing Product Overview
Accelerate ID/AST System - Carbepenem Resistance Testing Clinical Trial
Accelerate Pheno BC Kit
Accelerate Pheno BC Kit Product Overview
Accelerate Pheno BC Kit Clinical Trial
Accelerate Pheno System - Intra-Abdominal Infections Assay
Accelerate Pheno System - Intra-Abdominal Infections Assay Product Overview
Accelerate Pheno System - Urinary Tract Infections Assay
Accelerate Pheno System - Urinary Tract Infections Assay Product Overview
Accelerate Pheno System - Urinary Tract Infections Assay Clinical Trial
Accelerate PhenoTest svBP (Bacterial Pneumonia) Kit
Accelerate PhenoTest svBP (Bacterial Pneumonia) Kit Product Overview
BAC-Xtrax System
BAC-Xtrax System Product Overview
Diagnostic Test - Antibiotic-Resistant Biothreat Agents
Diagnostic Test - Antibiotic-Resistant Biothreat Agents Product Overview
Lower Respiratory Kit
Lower Respiratory Kit Product Overview
Accelerate Diagnostics Inc - Key Competitors
Accelerate Diagnostics Inc - Key Employees
Accelerate Diagnostics Inc - Key Employee Biographies
Accelerate Diagnostics Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Accelerate Diagnostics Inc, Recent Developments
May 09, 2019: Accelerate Diagnostics reports first quarter 2019 financial results
Feb 19, 2019: Accelerate Diagnostics reports 2018 fourth quarter and full-year financial results
Jan 06, 2019: Accelerate Diagnostics announces preliminary 2018 fourth quarter and full-year financial results
Nov 06, 2018: Accelerate Diagnostics reports Q3 2018 financial results
Sep 27, 2018: Accelerate Diagnostics announces resignation of Joan Martin as Head of Europe, Middle East, and Africa
Aug 07, 2018: Accelerate Diagnostics Receives New Innovative Technology Contract from Vizient for the Accelerate Pheno System
Aug 06, 2018: Accelerate Diagnostics reports Q2 2018 financial results
May 09, 2018: Accelerate Diagnostics reports Q1 2018 financial results
Apr 21, 2018: Accelerate Diagnostics announces sizeable release of new data at ECCMID 2018
Apr 12, 2018: Hampshire Hospitals NHS Foundation Trust Pioneers Use of Diagnostic Tools for Earlier Optimisation of Antibiotic Therapy for Sepsis Patients
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Accelerate Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview
Accelerate Diagnostics Inc Pipeline Products by Equipment Type
Accelerate Diagnostics Inc Pipeline Products by Indication
Accelerate Diagnostics Inc Ongoing Clinical Trials by Trial Status
Accelerate Diagnostics Inc, Key Facts
Accelerate Diagnostics Inc, Major Products and Services
Accelerate Diagnostics Inc Number of Pipeline Products by Development Stage
Accelerate Diagnostics Inc Pipeline Products Summary by Development Stage
Accelerate Diagnostics Inc Ongoing Clinical Trials by Trial Status
Accelerate Diagnostics Inc Ongoing Clinical Trials Summary
Accelerate ID/AST System - Secondary Infections - Product Status
Accelerate ID/AST System - Secondary Infections - Product Description
Accelerate ID/AST System - Secondary Infections - Bedside Versus Standard Microbiological Blood Culture Diagnostics: BEMIDIA Study
Accelerate ID/AST System - Wound Infections - Product Status
Accelerate ID/AST System - Wound Infections - Product Description
Accelerate ID/AST System - Wound Infections - Bedside Versus Standard Microbiological Blood Culture Diagnostics: BEMIDIA Study
Accelerate ID/AST System - Carbepenem Resistance Testing - Product Status
Accelerate ID/AST System - Carbepenem Resistance Testing - Product Description
Accelerate ID/AST System - Carbepenem Resistance Testing - Ultra Rapid Culture Independent Detection of High-priority Carbapenem Resistant Enterobacteriaceae Directly from Blood
Accelerate Pheno BC Kit - Product Status
Accelerate Pheno BC Kit - Product Description
Accelerate Pheno BC Kit - Randomized Trial Assessing the Clinical Impact of Fast Bacteria Identification and Phenotypic Antimicrobial Susceptibility Testing on Patients With Bacteremic Due to Gram-negative Rods
Accelerate Pheno BC Kit - Randomized Trial of Fast Bacterial Identification and Phenotypic Antimicrobial Susceptibility Testing in Patients With Positive Blood Cultures Using the Accelerate PhenoTest BC Kit, Performed on the Accelerate Pheno System as Compared with the Verigene BC-GP/GN
Accelerate Pheno System - Intra-Abdominal Infections Assay - Product Status
Accelerate Pheno System - Intra-Abdominal Infections Assay - Product Description
Accelerate Pheno System - Urinary Tract Infections Assay - Product Status
Accelerate Pheno System - Urinary Tract Infections Assay - Product Description
Accelerate Pheno System - Urinary Tract Infections Assay - Randomized Trial Assessing the Clinical Impact of Fast Bacteria Identification and Phenotypic Antimicrobial Susceptibility Testing on Patients With Bacteremic Due to Gram-negative Rods
Accelerate PhenoTest svBP (Bacterial Pneumonia) Kit - Product Status
Accelerate PhenoTest svBP (Bacterial Pneumonia) Kit - Product Description
BAC-Xtrax System - Product Status
BAC-Xtrax System - Product Description
Diagnostic Test - Antibiotic-Resistant Biothreat Agents - Product Status
Diagnostic Test - Antibiotic-Resistant Biothreat Agents - Product Description
Lower Respiratory Kit - Product Status
Lower Respiratory Kit - Product Description
Accelerate Diagnostics Inc, Key Employees
Accelerate Diagnostics Inc, Key Employee Biographies
Accelerate Diagnostics Inc, Subsidiaries
Glossary
List of Figures
Accelerate Diagnostics Inc Pipeline Products by Equipment Type
Accelerate Diagnostics Inc Pipeline Products by Development Stage
Accelerate Diagnostics Inc Ongoing Clinical Trials by Trial Status

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook